Skip to content

SHARE (Sharing Goals and Preferences) Study

SHARE (Sharing Goals and Preferences) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03392090
Enrollment
53
Registered
2018-01-05
Start date
2018-07-23
Completion date
2022-03-15
Last updated
2022-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Cancer

Keywords

Cancer

Brief summary

This research study is evaluating the usefulness of a video and questionnaire to help cancer patients think about the goals of their care.

Detailed description

The investigators are conducting a study with patients from Dana Farber Cancer Institute (DFCI) and DFCI-affiliate at St. Elizabeth's Hospital who are being treated for their cancer. The purpose of the study is to test the implementation of a short video, a brief questionnaire, and a wallet card designed to help patients understand and articulate their goals and preferences when making decisions about their cancer treatment and communicate these preferences to their clinicians. The short video and brief questionnaire were developed to help patients with cancer think about their goals of care and their treatment and information preferences and to prompt discussions with their health care team about these preferences. The wallet card is designed to help patients remember some key questions that may be useful as they make decisions about future treatments A pilot test will be completed to assess the feasibility and usability of the revised More Good Days video, brief questionnaire and wallet card in helping seriously-ill cancer patients think about what a good day means to them and test whether these tools can help patients to identify and communicate their medical treatment preferences and goals with their care team.

Interventions

OTHERMore Good Days video&brief questionnaire

Help patients with advanced cancer think about what a good day means to them and to help them think about questions they may have for their physicians when discussing treatments

Sponsors

American Cancer Society, Inc.
CollaboratorOTHER
Harvard Medical School (HMS and HSDM)
CollaboratorOTHER
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient who are receiving treatment at: * DFCI in the thoracic oncology group * DFCI-affiliated St. Elizabeth's Hospital and have progressed on 2nd line or later-line systemic therapies (chemotherapy, immunotherapy, biological, or targeted therapies) * Clinicians' schedules to identify patients with metastatic cancers who are considering or pursuing additional palliative therapy

Exclusion criteria

* Patients who are not interested in the study * Patients of physicians who opt out of participating * Patients whose physicians did not opt out, but whose physician does not think they are well suited for the study

Design outcomes

Primary

MeasureTime frameDescription
Enrollment2 years% of patients invited to participate who choose to enroll
Overall rating of intervention1 month% who rate intervention as good/very good/excellent.
Would recommend intervention to others1 month% who would recommend intervention to others with cancers like theirs

Secondary

MeasureTime frameDescription
Patient depression1 monthPatient Health Questionnaire-9 (PHQ-9) (9 items, score 0 to 27, higher = more depressed)
Hope1 monthHearth Hope Index (12 items, score 12 to 48, higher = more hope)
Preferred format for viewing video and completing questionnaire1 monthpreferences for watching alone vs. with family; in clinic vs. home, interest in accessing via electronic record portal
Quality of life-palliative care specific items1 monthPalliative care subscale of FACITPAL (14 items, score 0 to 56, higher = better quality of life)
Therapeutic Alliance1 monthHuman Connection Scale (16 items, score 16 to 64, higher = more therapeutic alliance)
FACIT-PAL Quality of Life1 monthFACIT-PAL instrument general quality of life (27 general items, score 0 to 108, higher=better quality of life)
Patient anxiety1 monthHospital Anxiety and Depression Scale (HADS) (score 0 to 21 for 7 anxiety items, higher=more anxiety)
Patient distress1 monthNational Comprehensive Cancer Network distress thermometer (score 0 to 10, higher worse distress)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026